GLATIRAMER ACETATE — all Canadian products
8 DINs
7 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is GLATIRAMER ACETATE, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02245619 | COPAXONE | TEVA CANADA LIMITED | Solution | Subcutaneous | GLATIRAMER ACETATE 20 MG | Marketed | |
| 02512173 | COPAXONE | TEVA CANADA LIMITED | Solution | Subcutaneous | GLATIRAMER ACETATE 40 MG | Approved | |
| 02456915 | COPAXONE | TEVA CANADA LIMITED | Solution | Subcutaneous | GLATIRAMER ACETATE 40 MG | Marketed | |
| 02460661 | GLATECT | PHARMASCIENCE INC | Solution | Subcutaneous | GLATIRAMER ACETATE 20 MG | Marketed | |
| 02541440 | GLATIRAMER ACETATE INJECTION | MYLAN PHARMACEUTICALS ULC | Solution | Subcutaneous | GLATIRAMER ACETATE 20 MG | Marketed | |
| 02481510 | TEVA-GLATIRAMER ACETATE | TEVA CANADA LIMITED | Solution | Subcutaneous | GLATIRAMER ACETATE 40 MG | Approved | |
| 02441446 | TEVA-GLATIRAMER ACETATE | TEVA CANADA LIMITED | Solution | Subcutaneous | GLATIRAMER ACETATE 20 MG | Approved | |
| 02233014 | COPAXONE | TEVA PHARMACEUTICAL INDUSTRIES LTD | Powder For Solution | Subcutaneous | GLATIRAMER ACETATE 20 MG | Cancelled Post Market |
Browse other molecules: